- Home
- DBVT vs DHAI Comparison
DBVT vs DHAI Comparison
Compare DBVT & DHAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- DHAI
- Stock Information
- Founded
- DBVT 2002
- DHAI 2007
- Country
- DBVT France
- DHAI United States
- Employees
- DBVT N/A
- DHAI N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- DHAI
- Sector
- DBVT Health Care
- DHAI
- Exchange
- DBVT Nasdaq
- DHAI NYSE
- Market Cap
- DBVT 250.5M
- DHAI 11.6M
- IPO Year
- DBVT N/A
- DHAI N/A
- Fundamental
- Price
- DBVT $10.30
- DHAI $0.24
- Analyst Decision
- DBVT Buy
- DHAI
- Analyst Count
- DBVT 4
- DHAI 0
- Target Price
- DBVT $14.81
- DHAI N/A
- AVG Volume (30 Days)
- DBVT 25.0K
- DHAI 5.8M
- Earning Date
- DBVT 07-29-2025
- DHAI 08-18-2025
- Dividend Yield
- DBVT N/A
- DHAI N/A
- EPS Growth
- DBVT N/A
- DHAI N/A
- EPS
- DBVT N/A
- DHAI N/A
- Revenue
- DBVT $3,497,000.00
- DHAI $69,573,000.00
- Revenue This Year
- DBVT $1,700.53
- DHAI N/A
- Revenue Next Year
- DBVT $535.67
- DHAI N/A
- P/E Ratio
- DBVT N/A
- DHAI N/A
- Revenue Growth
- DBVT N/A
- DHAI 5.40
- 52 Week Low
- DBVT $2.21
- DHAI $0.12
- 52 Week High
- DBVT $12.78
- DHAI $3.50
- Technical
- Relative Strength Index (RSI)
- DBVT 56.17
- DHAI 48.32
- Support Level
- DBVT $10.11
- DHAI $0.23
- Resistance Level
- DBVT $11.84
- DHAI $0.28
- Average True Range (ATR)
- DBVT 0.67
- DHAI 0.03
- MACD
- DBVT 0.05
- DHAI -0.00
- Stochastic Oscillator
- DBVT 60.06
- DHAI 23.10
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About DHAI DIH HOLDINGS US INC
DIH Holding US Inc is a provider of robotic devices used in physical rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions. Its products Armeo Power, Armeo Spring, Armeo Spring Pro, etc.